Catalyst Wire Dossier Catalyst Wire Dossier

Certolizumab pegol

certolizumab pegol · UCB
Drug timelines are a Plus or Pro feature.

40 regulatory and trial events tracked for Certolizumab pegol, covering 2010-12-30 to 2026-08-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

See pricing